Zanamivir for the treatment of influenza A and B infection in high-risk patients: A pooled analysis of randomized controlled trials

Archives of Internal Medicine

Volumn 161, Issue 2, 2001, Pages 212-217

  Lalezari, Jacob ^a   Campion, Katrina ^b   Keene, Oliver ^c   Silagy, Chris ^d  

^a Quest Clinical Research   (United States)

^b GLAXOSMITHKLINE   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PLACEBO; ZANAMIVIR;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; ASTHMA; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME; TREATMENT PLANNING; VERTIGO; VOMITING;

EID: 0035931304     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.2.212     Document Type: Article

References (31)

1. Influenza - Its impact and control
2. Human influenza
3. Influenza: Quantifying morbidity and mortality
4. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly
5. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic
6. Influenza vaccine effectiveness in preventing hospitalization among the elderly during type A and type B seasons
7. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-1990 epidemic
8. Influenza: Diagnosis, management, and prophylaxis
9. Immune response to influenza vaccination in a large healthy elderly population
10. Experience in the use of inactivated influenza vaccines in nursing homes
11. Antiviral activity of amantadine: A review of laboratory and clinical data
12. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine
13. Use of antivirals in influenza in the elderly: Prophylaxis and therapy
14. Amantadine, rimantadine, and related agents
15. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections
16. The efficacy and safety of inhaled zanamivir in the treatment of influenza in otherwise healthy and "high-risk" individuals in North America
17. Efficacy and safety of the orally inhaled neuraminidase inhibitor, zanamivir, in the treatment of influenza: A randomized, double-blind, placebo-controlled European Study
18. Randomised placebo controlled studies of inhaled zanamivir in the treatment of influenza A and B: Pooled efficacy analysis
19. Zanamivir for treatment of symptomatic influenza A and B in children 5 to 12 years of age: A randomised controlled trial
20. Inhaled zanamivir for the prevention of influenza in families
21. Pneumonia and influenza deaths during epidemics; implications for prevention
22. Pneumonia and Hong Kong influenza: A prospective study of the 1968-1969 epidemic
23. Impact of epidemic type A influenza in a defined adult population
24. Zanamivir, a new targeted therapy in the treatment of influenza: A patient perspective assessed by questionnaire
25. The effectiveness of vaccination against influenza in healthy, working adults
26. Socioeconomics of influenza and influenza vaccination in Europe
27. Problems in the control of epidemic influenza by vaccination
28. Pharmacokinetic evaluation of lung deposition of inhaled zanamivir in healthy volunteers
29. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers